| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.pfizerltd.co.in | |
| Market Cap | 18,902.96 Cr. | |
| Enterprise Value(EV) | 17,013.30 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 109.76 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 37.65 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.30 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 743.86 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 5.55 | Calculated using Price: 4,132.00 |
| Dividend Yield | 1.69 | Period Ending 2023-03 |
| No. of Shares Subscribed | 4.57 Cr. | 45,747,732 Shares |
| FaceValue | 10 | |
| About Pfizer Ltd. | ||
| Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis. | ||
| 1 Day |
|
-0.09% |
| 1 Week |
|
+0.74% |
| 1 Month |
|
-4.69% |
| 3 Month |
|
-2.01% |
| 6 Month |
|
+5.50% |
| 1 Year |
|
+9.63% |
| 2 Year |
|
-4.68% |
| 5 Year |
|
+31.61% |
| 10 Year |
|
+216.84% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 7.63 | 14.75 | 14.7 | 14.11 | 15.07 | 15.89 | 17.19 | 23.3 | 20.55 | |
| Return on Capital Employed (%) | 18.19 | 22.78 | 22.62 | 21.49 | 23.22 | 20.38 | 23.62 | 29.78 | 27.56 | |
| Return on Assets (%) | 5.75 | 11.22 | 10.95 | 10.36 | 11.25 | 12.2 | 13 | 17.24 | 16.09 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 1,973 | 2,164 | 2,419 | 2,683 | 3,011 | 3,395 | 2,393 | 2,864 | 3,207 | 3,273 | |
| Non Curr. Liab. | -35 | 66 | 62 | 52 | 37 | 136 | 85 | 136 | 38 | 24 | |
| Curr. Liab. | 609 | 658 | 780 | 954 | 892 | 873 | 774 | 853 | 657 | 614 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 2,547 | 2,888 | 3,261 | 3,690 | 3,940 | 4,405 | 3,252 | 3,854 | 3,903 | 3,911 | |
| Non Curr. Assets | 1,295 | 1,256 | 1,210 | 1,273 | 1,225 | 1,357 | 1,344 | 1,457 | 1,378 | 1,362 | |
| Curr. Assets | 1,252 | 1,614 | 2,033 | 2,403 | 2,702 | 3,013 | 1,873 | 2,361 | 2,493 | 2,549 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 2,547 | 2,888 | 3,261 | 3,690 | 3,940 | 4,405 | 3,252 | 3,854 | 3,903 | 3,911 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 1,853 | 2,012 | 1,966 | 1,969 | 2,082 | 2,152 | 2,239 | 2,611 | 2,425 | 2,219 | |
| Other Income | 72 | 87 | 101 | 114 | 167 | 184 | 81 | 63 | 101 | 137 | |
| Total Income | 1,925 | 2,099 | 2,067 | 2,083 | 2,249 | 2,336 | 2,320 | 2,674 | 2,526 | 2,356 | |
| Total Expenditure | -1,474 | -1,579 | -1,616 | -1,468 | -1,516 | -1,579 | -1,526 | -1,775 | -1,616 | -1,591 | |
| PBIDT | 451 | 520 | 451 | 615 | 733 | 757 | 794 | 899 | 910 | 765 | |
| Interest | -2 | -1 | -2 | -1 | -2 | -11 | -15 | -11 | -13 | -11 | |
| Depreciation | -131 | -58 | -63 | -66 | -71 | -103 | -109 | -115 | -106 | -75 | |
| Taxation | -138 | -165 | -180 | -188 | -231 | -133 | -171 | -160 | -200 | -165 | |
| Exceptional Items | -80 | 10 | 130 | 33 | -12 | ||||||
| PAT | 100 | 305 | 337 | 360 | 429 | 509 | 498 | 613 | 624 | 502 | |
| Adjusted EPS | 22 | 67 | 74 | 79 | 94 | 111 | 109 | 134 | 136 | 110 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 132 | 113 | 345 | 329 | 332 | 98 | 323 | 427 | 667 | 356 | |
| Cash Fr. Inv. | 103 | -89 | -701 | -250 | -238 | 35 | 1,530 | -469 | -575 | -36 | |
| Cash Fr. Finan. | -1,360 | -1 | -62 | -83 | -110 | -110 | -164 | -1,571 | -181 | -346 | |
| Net Change | -1,125 | 23 | -417 | -3 | -17 | 23 | 1,690 | -1,613 | -88 | -26 | |
| Cash & Cash Eqvt | 308 | 488 | 71 | 68 | 51 | 74 | 1,764 | 151 | 63 | 37 |
|
Thu, 11 Apr 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent PFIZER LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
Thu, 11 Apr 2024
Updates Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, ( SEBI Listing Regulations ) we hereby inform you that, upon recommendation of the Audit Committee, the Board of Directors of the Company has appointed M/s. Kishore Bhatia & Associates as Cost Auditors for the financial year ended March 31, 2024, to fill the casual vacancy caused by the resignation of M/s. R.A.& Co. |
|
Wed, 10 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018,we furnish herewith Certificate dated April 10, 2024, issued by KFin Technologies Limited,Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2024. |
| Wed, 24 Apr 2024 |
Close Within 52 Week Low Zone
|
MFI Below 20
|
Closing Near 200 SMA
|
| Tue, 23 Apr 2024 |
|
Close Within 52 Week Low Zone
|
William %R Bullish
|
